HighTower Advisors LLC Sells 39,677 Shares of Doximity, Inc. (NASDAQ:DOCS)

HighTower Advisors LLC lowered its position in Doximity, Inc. (NASDAQ:DOCS) by 61.3% in the third quarter, Holdings Channel.com reports. The institutional investor owned 25,054 shares of the company’s stock after selling 39,677 shares during the period. HighTower Advisors LLC’s holdings in Doximity were worth $1,091,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. FMR LLC lifted its stake in Doximity by 30.5% in the third quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after buying an additional 1,598,602 shares in the last quarter. William Blair Investment Management LLC lifted its position in Doximity by 15.8% in the 2nd quarter. William Blair Investment Management LLC now owns 6,404,068 shares of the company’s stock valued at $179,122,000 after acquiring an additional 873,682 shares in the last quarter. Clearbridge Investments LLC boosted its stake in Doximity by 7.1% in the 2nd quarter. Clearbridge Investments LLC now owns 5,853,035 shares of the company’s stock worth $163,709,000 after purchasing an additional 387,200 shares during the period. Renaissance Technologies LLC increased its holdings in Doximity by 23.1% during the 2nd quarter. Renaissance Technologies LLC now owns 1,603,202 shares of the company’s stock worth $44,842,000 after purchasing an additional 301,100 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Doximity by 28.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,267,067 shares of the company’s stock valued at $35,439,000 after purchasing an additional 281,239 shares during the period. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Stock Performance

DOCS opened at $52.71 on Wednesday. The stock has a fifty day moving average of $48.41 and a 200-day moving average of $38.36. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $61.75. The company has a market capitalization of $9.84 billion, a P/E ratio of 60.58, a P/E/G ratio of 4.16 and a beta of 1.40.

Analyst Ratings Changes

A number of research analysts recently issued reports on DOCS shares. Canaccord Genuity Group reiterated a “hold” rating and set a $60.00 price objective (up from $40.00) on shares of Doximity in a report on Wednesday, November 13th. Canaccord Genuity Group cut shares of Doximity from a “buy” rating to a “hold” rating and raised their price target for the stock from $40.00 to $60.00 in a research note on Wednesday, November 13th. Baird R W raised shares of Doximity to a “strong-buy” rating in a research report on Tuesday, September 17th. Wells Fargo & Company upgraded shares of Doximity from an “underweight” rating to an “equal weight” rating and increased their target price for the stock from $19.00 to $41.00 in a report on Friday, November 8th. Finally, Bank of America lifted their price target on shares of Doximity from $32.00 to $45.00 and gave the company a “neutral” rating in a research note on Monday, October 7th. Twelve analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $52.44.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.